米国の全国的なClostridioides difficile感染症と関連入院の負担は、2011年から2017年にかけて減少しており、これは主に医療関連感染（health care-associated infections）の低下によることが、米国疾病管理予防センター（CDC）のAlice Y. Guh氏ら新興感染症プログラム（EIP ...

C. difficileは偏性嫌気性の芽胞を持つグラム陽性桿菌です。かつてはClostridium属に分類されていましたが、Peptostreptococcaceae科に再分類され、Clostridiaceae科との区別と略称変更による混乱を避けるかたちで、Clostridioidesと新たに命名されました。 多くの抗菌薬に ...

日水製薬は6月1日、C.difficile（クロストリジウム・ディフィシル） ※1 の毒素を検出する簡易検査キット「TOX A/B QUIK CHEK」を発売した。このキットは、C.difficileが産生する毒素のうちトキシンAとトキシンBの2種類を検出できるのが特徴で、従来のトキシン ...

The clinical aspects of C. difficile infection (CDI) that are discussed include description of the disease spectrum and severity, and the signs, symptoms and clinical pathogenesis of CDI. An overview ...

CDI治療に用いられるFDXとVCM、血中濃度を指標とした従来のPK/PD評価法が使えない 慶應義塾大は3月16日、従来のpharmacokinetics ...

Toxigenic Clostridioides difficile (C. difficile) is a multiply antibiotic resistant, anaerobic bacterium that is among the leading causes of nosocomial infectious diarrhea worldwide. An estimated 130 ...

This article discusses the prevalence of Clostridioides difficile (C. difficile) infection in hospitals, the progress that’s been made in recent years in reducing hospital-acquired infections, and ...

Sometimes scientists look for new species in the jungle or deep in the oceans. Other times they look in hospital rooms. Researchers reported this week in Nature Genetics that a subset of Clostridium ...

New statistics indicate the number of people—particularly children—who contract the bacterial infection Clostridium difficile (C. difficile) has increased dramatically over the past few years. Mayo ...

C. difficile, a deadly bacterium that often lurks in hospital settings, can be effectively eliminated by frequent handwashing with soap and water, says Dr. Michael Libman, director of the division of ...

When used in combination with ceftriaxone, doxycycline appears to lower the risk of developing C difficile infection compared with ceftriaxone alone. C difficile is a major hospital pathogen, and risk ...